Notably, the metabolites were relevant to corticosterone, which had direct effects on ATGL, supporting the notion that glucocorticoids increase lipolysis through glucocorticoid-induced increases of lipase expression in response to treatment with HD-TE compared with NAFLD [32]. This evidence concerns the gene PNPLA2 and metabolic dysfunction-associated steatotic liver disease.